Hos voksne patienter med invasiv candidiasis, esophageal candidiasis eller invasiv aspergillose, som fik gentagne, daglige doser af CANCIDAS 50 mg, havde mild til fremskreden nyreinsufficiens dog ingen betydelig effekt på koncentrationen af caspofungin.
However, in adult patients with invasive candidiasis, oesophageal candidiasis, or invasive aspergillosis who received multiple daily doses of CANCIDAS 50 mg, there was no significant effect of mild to advanced renal impairment on caspofungin concentrations.